Randomized placebo-controlled trial of canakinumab in Schnitzler syndrome

Krause K, et al.

Pediatr Rheumatol · 2015

Grade ARCT

Key Findings

  • ●Randomized placebo-controlled study confirming canakinumab effectiveness
  • ●Only RCT conducted in Schnitzler syndrome

Referenced in (1 disease)

Schnitzler Syndrome
ID: manual-k-2015-randomized-placebocontrolled-trial